FibroBiologics prices $3M public offering

FibroBiologics (FBLG) announced the pricing of a best efforts public offering of an aggregate of 2,272,728 shares of its common stock and warrants to purchase up to 2,272,728 shares of common stock, at a combined public offering price of $1.32 per share and accompanying Warrant. The Warrants will have an exercise price of $1.32 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Warrants and will expire on the five-year anniversary of the date of Stockholder Approval. The closing of the offering is expected to occur on or about April 2, 2026, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.